The Effect of Second-Generation Antipsychotics Administration for 1-Year on the Platelet Activities in Patients With Schizophrenia: Retrospective Study |
Yoon-Seok, Oh
(Department of Psychiatry, College of Medicine, Konyang University)
Jong Wook, Lee (Konyang University Myunggok Medical Research Institute) Hong-Seok, Oh (Department of Psychiatry, College of Medicine, Konyang University) Seung-Jun, Kim (Department of Psychiatry, College of Medicine, Konyang University) Na-Hyun, Lee (Department of Psychiatry, College of Medicine, Konyang University) Woo Young, Im (Department of Psychiatry, College of Medicine, Konyang University) Ji-Woong, Kim (Department of Psychiatry, College of Medicine, Konyang University) |
1 | Masopust J, Maly R, Valis M. Risk of venous thromboembolism during treatment with antipsychotic agents. Psychiatry and Clinical Neurosciences 2012;66:541-552. DOI |
2 | Parker C, Coupland C, Cox JH. Antipsychotic drugs and risk of venous thromboembolism: nested case-control study. BMJ 2010;341:c4245. DOI |
3 | Kim HA, Lee JW, Kim SJ, Oh HS, Im WY, Kim JW. Second-generation antipsychotics activate platelets in antipsychotic-naive and antipsychotic-free patients with schizophrenia: a retrospective study. Int J Psychiatry Med 2020;55:105-113. DOI |
4 | Kim HA, Lee JW, Kim SJ, Oh HS, Im WY, Kim JW. Clozapine administration potentiate platelet activation in patients with schizophrenia: retrospective study. Korean J Psychosomatic Med 2018;26:188-193. DOI |
5 | Chapman ES, Sorette M, Hetherington E, Zelmanovic D, Kling G, Dugailliez J, Pujol-Moix N, Okrongly D. A rapid, automated flow cytometric method to measure activated degranulated platelets by density determination. Thromb Haemost 2003;89:1004-1015. DOI |
6 | Macey MG, Carty E, Webb L, Chapman ES, Zelmanovic D, Okrongly D, Rampton DS, Newland AC. Use of mean platelet component to measure platelet activation on the ADVIA 120 haematology system. Cytometry 1999;38:250-255. DOI |
7 | Semiz M, Yucel H, Kavakci O, Yildirim O, Zorlu A, Yilmaz MB, Kucukdurmaz Z, Canan F. Atypical antipsychotic use is an independent predictor for the increased mean platelet volume in patients with schizophrenia: a preliminary study. J Res Med Sci 2013;18:561-566. |
8 | Jang EJ, Lee JW, Kim SJ, Oh HS, Lee Nh, Im WY, Kim JW. A retrospective study on the effect of 1-year clozapine administration on platelet activity in patients with schizophrenia or schizoaffective disorder. Korean J Psychosomatic Med 2020;28:36-41. DOI |
9 | Kim DS, Ryu SH, Lee JW, Kim YD, Choi YC. Mean platelet component to measure platelet activation in ischemic stroke: preliminary study. J Korean Neurol Assoc 2002;20:223-226. |
10 | Pawlus J, Holub M, Kozuch M, Dabrowska M, Dobrzycki S. Serum myeloperoxidase levels and platelet activation parameters as diagnostic and prognostic markers in the course of coronary disease. Int J Lab Hematol 201032:320-328. |
11 | Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J 2005;150:1115-1121. DOI |
12 | Correll CU, Solmi M, Veronese N, Bortolato B, Rosson S, Santonastaso P, Thapa-Chhetri N, Fornaro M, Gallicchio D, Collantoni E, Pigato G, Favaro A, Monaco F, Kohler C, Vancampfort D, Ward PB, Gaughran F, Carvalho AF, Stubbs B. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry 2017;16:163-180. DOI |
13 | Correll CU, Detraux J, De Lepeleire J, De Hert M. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry 2015;14:119-136. DOI |
14 | Castillo-Sanchez M, Escurriola MF, Sanmartin MIF, Solntseva I, Baquero DB, Arno AG. Cardiovascular disease and mortality in people with schizophrenia or antipsychotic treatment: a cohort study in primary care. Psychiatry Res 2021 114233. Epub 2021 Oct 10. |
15 | Roberts CK and Sindhu KK. Oxidative stress and metabolic syndrome. Life Sci 2009;84:705-712. DOI |
16 | Santilli F, Lapenna D, La Barba S, Davi G. Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus. Free Radic Biol Med 2015;80:101-110. DOI |
17 | Hagg S, Bate A, Stahl M, spigset O. Associations between venous thromboembolism and antipsychotics. A study of the WHO database of adverse drug reactions. Drug Saf 2008;31:685-694. DOI |
18 | Jonsson AK, Schill J, Olsson H, Spigset O, Hagg S. Venous thromboembolism during treatment with antipsychotics: a review of current evidence. CNS Drugs 2018;32:47-64. DOI |
19 | Axelsson S, Hagg S, Eriksson AC, Lindahl TL, Whiss PA. In vitro effects of antipsychotics on human platelet adhesion and aggregation and plasma coagulation. Clin Exp Pharmacol Physiol 2007;34:775-780. DOI |
20 | Hert MD, Detraux J, Winkel RV, Yu W, Correll CU. Metabolic and cardiovascular adverse effects associated with anti-psychotic drugs. Nat Rev Endocrinol 2011;8:114-126. DOI |
21 | Hagg S, Spigset O. Antipsychotic-induced venous thromboembolism: a review of the evidence. CNS Drugs 2002;16:765-776. DOI |